Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L Davis

Showing results (91-100 of 400) with videos related to

Pageof 40
Sort By:
Journal of Chromatography|May 13, 1983
High-performance liquid chromatographic determination of tetrahydroaminoacridine in human and rat tissues using a rapid Sep-Pak C18 extractionJ Y Hsieh, R K Yang, K L Davis
The American Journal of Psychiatry|July 1, 1977
Deanol in tardive dyskinesiaK L Davis, P A Berger, L E Hollister
Journal of Clinical Psychopharmacology|October 1, 1982
The neuropharmacology of tardive dyskinesia, spontaneous dyskinesia, and other dystoniasS M Stahl, K L Davis, P A Berger
Psychiatry Research|December 1, 1981
Statistical power in biological psychiatryA B Rothpearl, R C Mohs, K L Davis
The American Journal of Psychiatry|September 1, 1975
Thyrotropin-releasing hormone in schizophreniaK L Davis, L E Hossister, P A Berger
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Effect Of Sample Size And Data Maturity On Parametric Survival Modeling Projections In Advanced CancerC N Graham, K L Davis, R K Goyal
Biological Psychiatry|November 24, 1999
The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's diseaseJ I Friedman, D N Adler, K L Davis
Psychopharmacology Communications|January 1, 1976
Tardive dyskinesia and depressive illnessK L Davis, P A Berger, L E Hollister
The New England Journal of Medicine|July 17, 1975
Letter: Choline for tardive dyskinesiaK L Davis, P A Berger, L E Hollister
Current Eye Research|July 1, 1990
Hormonal stimulation of 12(R)-HETE, a cytochrome P450 arachidonic acid metabolite in the rabbit corneaK L Davis, M W Dunn, M L Schwartzman
Pageof 40

Showing results (91-100 of 400) with videos related to

Sort By:
Pageof 40
Journal of Chromatography|May 13, 1983
High-performance liquid chromatographic determination of tetrahydroaminoacridine in human and rat tissues using a rapid Sep-Pak C18 extractionJ Y Hsieh, R K Yang, K L Davis
The American Journal of Psychiatry|July 1, 1977
Deanol in tardive dyskinesiaK L Davis, P A Berger, L E Hollister
Journal of Clinical Psychopharmacology|October 1, 1982
The neuropharmacology of tardive dyskinesia, spontaneous dyskinesia, and other dystoniasS M Stahl, K L Davis, P A Berger
Psychiatry Research|December 1, 1981
Statistical power in biological psychiatryA B Rothpearl, R C Mohs, K L Davis
The American Journal of Psychiatry|September 1, 1975
Thyrotropin-releasing hormone in schizophreniaK L Davis, L E Hossister, P A Berger
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Effect Of Sample Size And Data Maturity On Parametric Survival Modeling Projections In Advanced CancerC N Graham, K L Davis, R K Goyal
Biological Psychiatry|November 24, 1999
The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's diseaseJ I Friedman, D N Adler, K L Davis
Psychopharmacology Communications|January 1, 1976
Tardive dyskinesia and depressive illnessK L Davis, P A Berger, L E Hollister
The New England Journal of Medicine|July 17, 1975
Letter: Choline for tardive dyskinesiaK L Davis, P A Berger, L E Hollister
Current Eye Research|July 1, 1990
Hormonal stimulation of 12(R)-HETE, a cytochrome P450 arachidonic acid metabolite in the rabbit corneaK L Davis, M W Dunn, M L Schwartzman
Pageof 40